Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists
-
Published:2021-01-11
Issue:6
Volume:394
Page:1113-1131
-
ISSN:0028-1298
-
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
-
language:en
-
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol
Author:
Spek Annabel, Li Bingsheng, Rutz Beata, Ciotkowska Anna, Huang Ru, Liu Yuhan, Wang Ruixiao, Strittmatter Frank, Waidelich Raphaela, Stief Christian G., Hennenberg MartinORCID
Abstract
AbstractNon-adrenergic prostate smooth muscle contractions may account for the limited effectiveness of α1-adrenoceptor antagonists, which are the first-line option for medical treatment of voiding symptoms suggestive of benign prostatic hyperplasia. In non-human prostates, purinergic agonists induce contractions reaching similar magnitudes as α1-adrenergic contractions. However, evidence for the human prostate is highly limited, and pointed to much weaker purinergic contractions. Here, we examined contractions of different purinergic agonists in human prostate tissues. Tissues were obtained from radical prostatectomy. Contractions were studied in an organ bath, and expression of purinergic receptors was studied by RT-PCR. Electric field stimulation (EFS)–induced contractions amounted to 104% of KCl-induced contractions (95% CI: 84–124%). From all tested agonists, only ATP induced concentration-dependent contractions, reaching an average maximum of 18% (12–24%) of KCl. Maximum tensions following application of other agonists averaged to 7.1% of KCl for α,β-methylene-ATP (1.8–12.4%), 3.9% for β,γ-methylene-ATP (2.0–5.4%), 3.1% for 2-methylthio-ATP (− 0.1–6.3%), and 5.1% for ATPγS (1.0–9.2%). Responses were not affected by the P2X antagonist NF023 or the P2Y antagonist PPADS. mRNA expression of P2X1-4 correlated with expression of a marker for catecholaminergic nerves, although neither ATP, NF023, nor PPADS changed EFS-induced contractions. Correlation between expression of receptors and the smooth muscle marker calponin was not observed. Our findings point to a low relevance of purinergic contractions in the human prostate, compared to other contractile stimuli in the human prostate and compared to purinergic contractions in non-human prostates. Purinergic contractions in the human prostate are not sensitive to NF023 or PPADS.
Funder
Deutsche Forschungsgemeinschaft Bayerische Gleichstellungsförderung China Scholarship Council
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference50 articles.
1. Abrams P (1994) New words for old: lower urinary tract symptoms for “prostatism”. BMJ 308:929–930. https://doi.org/10.1136/bmj.308.6934.929 2. Alcaraz A, Hammerer P, Tubaro A, Schroder FH, Castro R (2009) Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol 55:864–873. https://doi.org/10.1016/j.eururo.2008.11.011 3. Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA, CGTP Collaborators, Abbracchio MP, Alexander W, al-hosaini K, Bäck M, Beaulieu JM, Bernstein KE, Bettler B, Birdsall NJM, Blaho V, Bousquet C, Bräuner-Osborne H, Burnstock G, Caló G, Castaño JP, Catt KJ, Ceruti S, Chazot P, Chiang N, Chun J, Cianciulli A, Clapp LH, Couture R, Csaba Z, Dent G, Singh KD, Douglas SD, Dournaud P, Eguchi S, Escher E, Filardo E, Fong TM, Fumagalli M, Gainetdinov RR, Gasparo M, Gershengorn M, Gobeil F, Goodfriend TL, Goudet C, Gregory KJ, Gundlach AL, Hamann J, Hanson J, Hauger RL, Hay D, Heinemann A, Hollenberg MD, Holliday ND, Horiuchi M, Hoyer D, Hunyady L, Husain A, Ijzerman AP, Inagami T, Jacobson KA, Jensen RT, Jockers R, Jonnalagadda D, Karnik S, Kaupmann K, Kemp J, Kennedy C, Kihara Y, Kozielewicz P, Kreienkamp HJ, Kukkonen JP, Langenhan T, Leach K, Lecca D, Lee JD, Leeman SE, Leprince J, Lolait SJ, Lupp A, Macrae R, Maguire J, Mazella J, McArdle CA, Melmed S, Michel MC, Miller L, Mitolo V, Mouillac B, Murphy PM, Nahon JL, Norel X, Nyimanu D, O’Carroll AM, Offermanns S, Panaro MA, Pertwee RG, Pin JP, Prossnitz E, Ramachandran R, Reinscheid RK, Rondard P, Rovati GE, Ruzza C, Sanger G, Schöneberg T, Schulte G, Schulz S, Segaloff DL, Serhan CN, Stoddart LA, Sugimoto Y, Summers R, Tan V, Thomas W, Timmermans PBMWM, Tirupula K, Tulipano G, Unal H, Unger T, Vanderheyden P, Vaudry D, Vaudry H, Vilardaga JP, Walker CS, Ward DT, Wester HJ, Willars GB, Williams TL, Woodruff TM, Yao C (2019a) The concise guide to pharmacology 2019/20: G protein-coupled receptors. Br J Pharmacol 176(Suppl 1):S21–S141. https://doi.org/10.1111/bph.14748 4. Alexander SPH, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA, CGTP Collaborators, Aldrich RW, Becirovic E, Biel M, Catterall WA, Conner AC, Davies P, Delling M, di Virgilio F, Falzoni S, George C, Goldstein SAN, Grissmer S, Ha K, Hammelmann V, Hanukoglu I, Jarvis M, Jensen AA, Kaczmarek LK, Kellenberger S, Kennedy C, King B, Lynch JW, Perez-Reyes E, Plant LD, Rash LD, Ren D, Sivilotti LG, Smart TG, Snutch TP, Tian J, van den Eynde C, Vriens J, Wei AD, Winn BT, Wulff H, Xu H, Yue L, Zhang X, Zhu M (2019b) The concise guide to pharmacology 2019/20: ion channels. Br J Pharmacol 176(Suppl 1):S142–S228. https://doi.org/10.1111/bph.14749 5. Angulo J, Cuevas P, Fernandez A, La Fuente JM, Allona A, Moncada I, Saenz de Tejada I (2012) Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck. J Sex Med 9:2293–2306. https://doi.org/10.1111/j.1743-6109.2012.02821.x
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|